Date and time: Nov. 15, 3:30 p.m. – 4 p.m.
Location: New York Marriott at the Brooklyn Bridge
Topic: “30 Tips in 30 Minutes on How to Be Cyber Secure”
Speakers: Gina Rubel, Esq. and Jessica Grayson
“30 Tips in 30 Minutes to be Cyber Secure” will be presented at the Legal Marketing Association Northeast conference on Nov. 15, in Brooklyn, New York, by legal industry experts Gina Rubel, Furia Rubel Communications’ president and CEO, and Jessica Grayson, Phillips Nizer LLP’s chief business development officer.
In life and business, reputation is everything. It only takes one misstep to cause irreparable damage to the reputation of a law firm or its attorneys. And it’s not if, but when, because life happens, cyberattacks happen, and data breaches happen.
In a globally connected world, data breaches are inevitable. A business falls victim to a ransomware attack every 13 seconds. Thirty-one percent of organizations have experienced cyberattacks on operational infrastructure. In fact, the global cost of online crime is expected to reach $6 trillion by 2021.
Rubel and Grayson will provide tips for what legal markets can do to proactively protect their digital assets.
With more than 50 engaging speakers across 25 conference sessions, there’s something for legal marketers at every level and firm size at #LMANE19. Explore the full conference agenda to learn more.
About Furia Rubel Marketing and Public Relations: Furia Rubel Marketing and Public Relations is an integrated and strategic marketing, public relations and crisis management agency based in Bucks County, Pa. The certified woman-owned agency provides strategic planning, marketing, public relations, crisis management, business development, content marketing, and social media services to a wide array of professional service clients. Furia Rubel represents law firms and legal organizations, educational, nonprofit and religious organizations, financial, banking and accounting companies, governments and municipalities, behavioral health and elder care organizations, and pharmaceutical and biotech companies.
